{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-26-000041","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2026-08-03T21:01:56+00:00","discovered_at":"2026-08-03T21:04:02.972117+00:00","generated_at":"2026-08-03T21:04:17.662683+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Viemed Q2 2026 revenue $78.1M record, up 23.9% YoY; raises FY revenue guidance","bullets":["Net revenue $78.1M (record), up 23.9% YoY; net income $2.8M ($0.07 diluted EPS).","Adjusted EBITDA $13.7M, down 4% YoY due to prior-year non-recurring gain of $1.0M.","Ventilator patients 12,635 (+4% YoY); PAP therapy patients 37,825 (+44% YoY).","Repurchased 530,802 shares at avg $9.65 for $5.1M in Q2.","FY 2026 revenue guidance raised to $314-320M (prev $312-320M); Adj. EBITDA guidance narrowed to $64-68M (prev $65-69M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-26-000041","json":"https://secwatch.observer/filing/0001729149-26-000041.json","markdown":"https://secwatch.observer/filing/0001729149-26-000041.md","text":"https://secwatch.observer/filing/0001729149-26-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/0001729149-26-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/vmd-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T21:04:17.662683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}